• Hashtag: #ProstateQA

    Online Q&A in recognition of National Prostate Health Month
    September 22, 2014.  10:00am - 11:00am, EDT

    In recognition of National Prostate Health Month (September 2014), Patients and Research, the Men’s Health Network, Prostate Cancer Canada and Ward Health are proud to host an hour-long conversation focused on prostate cancer testing, awareness and screening.   Joining the discussion will be David Taylor, Professor Emeritus UCL London, Prostate Cancer Canada and the Men’s Health Network.

    Follow the discussion on September 22nd on twitter using #ProstateQA or on this page.  Thanks again to Professor David Taylor, Prostate Cancer Canada and the Mens’ Health Network for joining our #ProstateQA.

  • Prostate cancer kills more than 300,000 men a year world-wide, 90 per cent of whom are older than age 65. At the same time, centres like the University College London Hospital (UCLH) are finding that past problems with interpreting PSA data have often been associated with the biopsy techniques often used following the finding of an elevated PSA level.

    Questions of when and whom to test, how to treat and where to focus precious resources in the fight against cancer are explored by David Taylor, Emeritus Professor of Pharmaceutical and Public Health Policy, University College London.

  • Patient organizations from 33 different countries assembled in Brussels on May 12 and 13th for the 8th annual European Patients’ Rights conference to discuss among other things the significant role patients can and should play to support the development of innovative treatments that prevent, manage and cure disease.

    The key themes that arose from the discussion about innovation were trust, collaboration, and communication.

  • This year, the European Cystic Fibrosis Society’s Clinical Trial Network (ECFS-CTN) celebrates its fifth anniversary. To celebrate this milestone, it seemed appropriate to highlight the excellent work this network is doing in facilitating high-quality, efficient clinical trials for cystic fibrosis (CF) treatments. One of the key reasons for this network’s success is its strong emphasis on the involvement of patient organisations in clinical research.

  • According to a national public opinion poll commissioned by Research!America, which was published in June 2013, more than two thirds (72%) of Americans says it is likely they would participate in a clinical trial if recommended by their doctor, while only 22% can recall a health care professional ever talking to them about medical research. The results of this survey clearly point to the need for improved education about the importance and benefits of clinical trials.

Pages